SLI 3025288 / CH0030252883
2’028.79
Pkt
36.07
Pkt
1.81
%
12:26:57
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu SLI-Werten
| 11:32 | Nestlé Hold | Deutsche Bank AG | |
| 24.03.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 24.03.26 | Novartis Buy | Deutsche Bank AG | |
| 24.03.26 | Givaudan Hold | Deutsche Bank AG | |
| 23.03.26 | Richemont Sector Perform | RBC Capital Markets | |
| 23.03.26 | ABB Sector Perform | RBC Capital Markets | |
| 23.03.26 | Novartis Neutral | UBS AG | |
| 23.03.26 | Richemont Overweight | JP Morgan Chase & Co. | |
| 23.03.26 | Swiss Re Underweight | Barclays Capital | |
| 20.03.26 | Novartis Equal Weight | Barclays Capital | |
| 20.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 19.03.26 | ABB Sector Perform | RBC Capital Markets | |
| 19.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Nestlé Sector Perform | RBC Capital Markets | |
| 18.03.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.03.26 | UBS Underweight | Barclays Capital | |
| 17.03.26 | Givaudan Overweight | Barclays Capital | |
| 17.03.26 | Givaudan Neutral | UBS AG | |
| 12.03.26 | Roche Hold | Deutsche Bank AG | |
| 12.03.26 | Roche Overweight | Barclays Capital | |
| 12.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.03.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | Roche Hold | Deutsche Bank AG | |
| 10.03.26 | UBS Underweight | Barclays Capital | |
| 10.03.26 | Givaudan Overweight | Barclays Capital | |
| 09.03.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 09.03.26 | Roche Overweight | Barclays Capital | |
| 09.03.26 | Roche Hold | Deutsche Bank AG | |
| 09.03.26 | Roche Outperform | Bernstein Research | |
| 09.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.03.26 | Roche Underperform | Jefferies & Company Inc. | |
| 09.03.26 | UBS Outperform | RBC Capital Markets | |
| 06.03.26 | Richemont Buy | UBS AG | |
| 06.03.26 | Roche Buy | UBS AG | |
| 06.03.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 06.03.26 | Roche Neutral | Goldman Sachs Group Inc. |